Zobrazeno 1 - 10
of 3 485
pro vyhledávání: '"A. FASSIO"'
Autor:
G. Adami, S. Zanon, A. Fassio, G. Pesarini, M. Pighi, R. Scarsini, D. Tavella, M. Rossini, D. Gatti, F. Ribichini
Publikováno v:
Reumatismo (2024)
Objective. Diffuse idiopathic skeletal hyperostosis (DISH) is a common disorder characterized by ossification of tendons and ligaments. DISH has been largely associated with an increased risk of metabolic syndrome and type 2 diabetes. The objective o
Externí odkaz:
https://doaj.org/article/c8a0762e1e7f4959bf005cf9a79080d7
Autor:
A. Fassio, G. Porciello, G. Carioli, E. Palumbo, S. Vitale, A. Luongo, C. Montagnese, M. Prete, M. Grimaldi, R. Pica, E. Rotondo, L. Falzone, I. Calabrese, A. Minopoli, B. Grilli, M. Cuomo, P.C. Fiorillo, C. Evangelista, E. Cavalcanti, M. De Laurentiis, D. Cianniello, C. Pacilio, M. Pinto, G. Thomas, M. Rinaldo, M. D’Aiuto, D. Serraino, S. Massarut, A. Steffan, F. Ferraù, R. Rossello, F. Messina, F. Catalano, G. Adami, F. Bertoldo, M. Libra, A. Crispo, E. Celentano, C. La Vecchia, L.S.A. Augustin, D. Gatti
Publikováno v:
Reumatismo, Vol 76, Iss 1 (2024)
Objective. To report cross-sectionally serum levels of 25-hydroxyvitamin D [25(OH)D] in women living in Italy within 12 months from breast cancer (BC) diagnosis. Methods. Baseline data were obtained from 394 women diagnosed with primary BC, enrolle
Externí odkaz:
https://doaj.org/article/1c96e38096d54b6abd2cca1d871267f5
Autor:
G. Adami, L. Idolazzi, C. Benini, E. Fracassi, A. Carletto, O. Viapiana, D. Gatti, M. Rossini, A. Fassio
Publikováno v:
Reumatismo, Vol 75, Iss 1 (2023)
Psoriatic arthritis (PsA) is an inflammatory disease characterized by peripheral and axial involvement. Biological disease-modifying antirheumatic drugs (bDMARDs) are the mainstream treatment for PsA and bDMARDs retention rate is a proxy for the drug
Externí odkaz:
https://doaj.org/article/552f36e513d54a8ea0145d79447179a4
Publikováno v:
IEEE AICT2024 Conference Proceedings
Deep learning has revolutionized various fields by enabling highly accurate predictions and estimates. One important application is probabilistic prediction, where models estimate the probability of events rather than deterministic outcomes. This app
Externí odkaz:
http://arxiv.org/abs/2409.12535
The biomedical field is among the sectors most impacted by the increasing regulation of Artificial Intelligence (AI) and data protection legislation, given the sensitivity of patient information. However, the rise of synthetic data generation methods
Externí odkaz:
http://arxiv.org/abs/2404.16638
Autor:
G. Adami, A. Giollo, A. Fassio, C. Benini, E. Bertoldo, F. Bertoldo, G. Orsolini, L. Idolazzi, O. Viapiana, S. Giannini, G. Passeri, E. Tacconelli, C. Micheletto, D. Gatti, M. Rossini
Publikováno v:
Reumatismo, Vol 72, Iss 4 (2021)
The role of 25-OH-vitamin D in the assessment of coronavirus disease 19 (COVID-19) has not been investigated. We sought to investigate the prevalence of 25-OH-vitamin D deficiency among COVID-19 patients, and to determine the associations between 25-
Externí odkaz:
https://doaj.org/article/9a50c864490741ff8e86367c49d0eeb6
Publikováno v:
Reumatismo, Vol 72, Iss 2 (2020)
In this retrospective study, we intended to investigate the baseline fracture risk profile in patients who started treatment with different anti-osteoporotic medications. We analyzed retrospectively the fracture risk calculated with DeFRA, a validate
Externí odkaz:
https://doaj.org/article/a6825f15bd1a4020ba0f58a50a28f766
Autor:
A. Fassio, D. Gatti, P. Gisondi, G. Girolomoni, O. Viapiana, A. Giollo, M. Zamboni, M. Rossini, L. Idolazzi
Publikováno v:
Reumatismo, Vol 69, Iss 3, Pp 105-110 (2017)
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects joints, connective tissues and the axial skeleton. Metabolic syndrome is an independent risk factor for psoriasis (Pso) development and is associated with more severe forms of P
Externí odkaz:
https://doaj.org/article/c5635c2d40a144f880b85cb404ab47a2
Publikováno v:
Reumatismo, Vol 69, Iss 1, Pp 9-15 (2017)
Osteonecrosis of the jaw (ONJ) is a rare adverse event of antiresorptive drugs such as bisphosphonates (BP) and denosumab (DMAb). The diagnosis of ONJ is considered in cases where exposed bone in the maxillofacial region does not heal within 8 weeks
Externí odkaz:
https://doaj.org/article/7f694f8a0e4e4d86b42bc2879a0e2bed
Publikováno v:
Reumatismo, Vol 71, Iss 2 (2019)
Not available
Externí odkaz:
https://doaj.org/article/14d4f1c6e00d4366b6b2f35ea657b9e0